Condition: Diarrhea, Infantile · Enteropathy · Sponsor: Children's Hospital of Fudan University
This study will seek to determine if whole genome sequencing (WGS) improves diagnostic rates, and outcomes for congenital diarrhea and enteropathy (CODE) patients. The investigator will enroll 180 patients in a randomized controlled study to either WGS or whole exome sequencing (WES). This study is designed to evaluate whether CODE patients would benefit from WGS guided precision medicine.
This description comes directly from the study's public registry record.
Ying Huang, MD, PhD · +862164931727 · yhuang815@163.com
Lin Wang, MD,PhD · 13817510412 · wanglin546974055@163.com
Always discuss trial participation with your own doctor first.
| Ying Huang | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04528303